Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies

SIMPLE SUMMARY: Reprogramming of glucose metabolism is a hallmark of cancer and can be targeted by therapeutic agents. Some metabolism regulators, such as ivosidenib and enasidenib, have been approved for cancer treatment. Currently, more advanced and effective glucose metabolism enzyme-targeted ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi, Li, Qiong, Huang, Zhao, Li, Bowen, Nice, Edouard C., Huang, Canhua, Wei, Liuya, Zou, Bingwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559313/
https://www.ncbi.nlm.nih.gov/pubmed/36230492
http://dx.doi.org/10.3390/cancers14194568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559313/
https://www.ncbi.nlm.nih.gov/pubmed/36230492
http://dx.doi.org/10.3390/cancers14194568

Ejemplares similares